160 related articles for article (PubMed ID: 37250877)
1. Role of Lactoferrin in Treatment of Bile Duct Ligation-Induced Hepatic Fibrosis in Rats: Impact on Inflammation and TGF-β1/Smad2/α SMA Signaling Pathway.
Al-Najjar AH; Ayob AR; Awad AS
J Clin Exp Hepatol; 2023; 13(3):428-436. PubMed ID: 37250877
[TBL] [Abstract][Full Text] [Related]
2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
4. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
6. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
7. Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells.
Chen YH; Lan T; Li J; Qiu CH; Wu T; Gou HJ; Lu MQ
World J Gastroenterol; 2012 Dec; 18(48):7158-65. PubMed ID: 23326120
[TBL] [Abstract][Full Text] [Related]
8. Diacerein ameliorates cholestasis-induced liver fibrosis in rat via modulating HMGB1/RAGE/NF-κB/JNK pathway and endoplasmic reticulum stress.
Abdelfattah AM; Mahmoud SS; El-Wafaey DI; Abdelgeleel HM; Abdelhamid AM
Sci Rep; 2023 Jul; 13(1):11455. PubMed ID: 37454204
[TBL] [Abstract][Full Text] [Related]
9. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
11. Testicular orphan receptor 4 induced hepatic stellate cells activation via the regulation of TGF-β receptor Ⅰ/Smad2/3 signaling pathway.
Fu Y; Zhou Y; Mu Y; Lv Y; Chen G; Zhang H; Liu P; Chen J
Ann Hepatol; 2023; 28(1):100775. PubMed ID: 36280014
[TBL] [Abstract][Full Text] [Related]
12. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
16. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
17. The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways.
Esmail MM; Saeed NM; Michel HE; El-Naga RN
Toxicol Lett; 2021 Sep; 347():23-35. PubMed ID: 33961984
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
19. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
20. Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts.
Kim SM; Park KC; Kim HG; Han SJ
Hepatol Res; 2008 Aug; 38(8):800-9. PubMed ID: 18462380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]